Plaque Psoriasis: eMedicine Dermatology
Links shared publicly online about this topic.
- 1,225total visits
Plaque Psoriasis: eMedicine Dermatology
View full resource at emedicine.medscape.com
Tags: Dermatology, Skin, Psoriasis, Genetic, Disease and Condition
Most Recently Shared on September 9, 2010 at 11:44 am By:
In plaque psoriasis, ustekinumab improves mental/QOL and adalimumab is effective across many subgroups of patients: http://bit.ly/9MSdYm
Also Shared By:
Arch Dermatol -- Abstract: Comparative Effectiveness of Commonly Used Systemic Treatments or Phototherapy for Moderate to Severe Plaque Psoriasis in the Clinical Practice Setting, April 2012, Gelfand et al. 148 (4): 487
archderm.ama-assn.org — “Archives of Dermatology is a monthly professional medical journal published by the American Medical Association. Archives of Dermatology publishes original, peer-reviewed reports and discussions that address the effectiveness of diagnosis and treatment in medical and surgical dermatology, pediatric and geriatric dermatology, and oncologic and aesthetic dermatologic surgery” View full resource at archderm.ama-assn.org
Most Recently Shared on April 30, 2012 at 11:58 pm By:
National Psoriasis Foundation Dermatology and Health Organization
RT @JournaloftheDNA Study Compares Effectiveness of #Psoriasis Treatments http://t.co/dHBJzLmW #dermatology
Investigational Psoriasis Drug Reduces Vessel Inflammation : Skin & Allergy News
skinandallergynews.com — “Skin & Allergy News Digital Network is the online destination and multimedia properties of Skin & Allergy News, the independent news publication for the dermatology community. Our breaking news covers all areas of medical dermatology, dermatologic surgery, and aesthetic dermatology. We also provide the news by specialty interest: acne and rosacea, atopic dermatitis and eczema, cutaneous oncology, hair and nails, infectious diseases, pediatric dermatology, psoriasis and rheumatologic disorders, s” View full resource at skinandallergynews.com
Most Recently Shared on March 27, 2012 at 8:06 pm By:
Skin & Allergy News Health News
#AAD12 An investigational first-in-class drug not only improved plaque psoriasis but reduced vessel inflammation http://t.co/RzlHq3aa
Top-line data from Provectus' PH-10 Phase 2 trial on plaque psoriasis
news-medical.net — “Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced top-line data for the company's randomized controlled trial (RCT) of PH-10 for mild-to-moderate plaque psoriasis.” View full resource at news-medical.net
Most Recently Shared on March 19, 2012 at 11:57 am By:
Top-line data from Provectus' PH-10 Phase 2 trial on plaque psoriasis: Provectus Pharmaceuticals, Inc., a develo... http://t.co/DK5y94Mo
Medical News: Heart Risk Unclear for Psoriasis Drugs - in Dermatology, Psoriasis from MedPage Today
medpagetoday.com — “Preliminary signals of excess cardiovascular risk with two monoclonal antibodies used for treating plaque psoriasis were not confirmed in a meta-analysis, but the analysis may not have been sufficient” View full resource at medpagetoday.com
Most Recently Shared on August 29, 2011 at 10:28 pm By:
Roger D. Jones, PhD PhD, Doctor, Health Executive, and Health Social Media
Medical News: Heart Risk Unclear for Psoriasis Drugs - http://t.co/eXLXBbW from @medpagetoday #health #medicine
Medical News: Heart Risk Unclear for Psoriasis Drugs - in Dermatology, Psoriasis from MedPage Today
medpagetoday.com — “Preliminary signals of excess cardiovascular risk with two monoclonal antibodies used for treating plaque psoriasis were not confirmed in a meta-analysis, but the analysis may not have been sufficient” View full resource at medpagetoday.com
Most Recently Shared on August 24, 2011 at 6:05 pm By:
Heart risk unclear for psoriasis drugs: http://t.co/mee4ql9
Medical News: Heart Risk Unclear for Psoriasis Drugs - in Dermatology, Psoriasis from MedPage Today
medpagetoday.com — “Preliminary signals of excess cardiovascular risk with two monoclonal antibodies used for treating plaque psoriasis were not confirmed in a meta-analysis, but the analysis may not have been sufficient” View full resource at medpagetoday.com
Most Recently Shared on August 24, 2011 at 5:16 pm By:
Heart Risk Unclear for Psoriasis Drugs (CME/CE) http://t.co/oeQyZ6n
Topical coal tar preparations in the treatment of chronic plaque psoriasis: a review - page 2 | Clinical Dermatology
findarticles.com — “Topical coal tar preparations in the treatment of chronic plaque psoriasis: a review from Clinical Dermatology provided by Find Articles at BNET” View full resource at findarticles.com
Most Recently Shared on June 15, 2011 at 4:53 pm By:
National Psoriasis Foundation Dermatology and Health Organization
RT @hchang316 Topical coal tar preparations in treatment of plaque #psoriasis: Clinical Dermatology http://t.co/ZQdq35Z @cbsmoneywatch
Coast Dermatology Medical Blog » Dead Sea Climatotherapy May Benefit Patients With Plaque Psoriasis.
blog.coastdermatology.com — “Coast Dermatology Medical Blog » Dead Sea Climatotherapy May Benefit Patients With Plaque Psoriasis.” View full resource at blog.coastdermatology.com
Most Recently Shared on May 31, 2011 at 3:38 pm By:
MedWire News - Dermatology - Dead Sea climatotherapy more effective for early-onset psoriasis
medwire-news.md — “MedWire News Dead Sea climatotherapy is not only highly effective for treatment of plaque psoriasis, but has the greatest effect on early- versus late-onset forms of the disease, report researchers. MedWire News” View full resource at medwire-news.md
Most Recently Shared on May 31, 2011 at 9:20 am By:
Dead Sea climatotherapy more effective for early-onset psoriasis http://bit.ly/kI0kUR #psoriasis
Arch Dermatol -- Abstract: Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet: Efficacy and Safety Results From REACH, a Randomized, Placebo-Controlled, Double-blind Trial, April 2011, Leonardi et al. 147 (4): 42
archderm.ama-assn.org — “Archives of Dermatology is a monthly professional medical journal published by the American Medical Association. Archives of Dermatology publishes original, peer-reviewed reports and discussions that address the effectiveness of diagnosis and treatment in medical and surgical dermatology, pediatric and geriatric dermatology, and oncologic and aesthetic dermatologic surgery” View full resource at archderm.ama-assn.org
Most Recently Shared on April 13, 2011 at 1:29 pm By:
PsoriasisTx.com Dermatology and Health Site
C. Leonardi et al. Adalimumab for Treatment of Moderate to Severe Chronic Plaque #Psoriasis of the Hands and Feethttp://ow.ly/4zgyP
Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis - Maza - 2011 - Journal of the European Academy of Dermatology and Venereology - Wiley Online Library
onlinelibrary.wiley.com — “Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis - Maza - 2011 - Journal of the European Academy of Dermatology and Venereology - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on March 10, 2011 at 12:26 pm By:
Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence... http://bit.ly/ialLpN
Expression of tachykinins and their receptors in plaque psoriasis with pruritus - Amatya - British Journal of Dermatology - Wiley Online Library
onlinelibrary.wiley.com — “Expression of tachykinins and their receptors in plaque psoriasis with pruritus - Amatya - British Journal of Dermatology - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on February 8, 2011 at 4:06 am By:
Expression of tachykinins and their receptors in plaque psoriasis with pruritus: Conclusions  Tachykinins may ... http://bit.ly/ggEeWe
Amgen, Pfizer present Enbrel new trial results against psoriasis at 69th AAD meeting in New Orleans, La
news-medical.net — “Amgen and Pfizer Inc. today announced results from a new trial that demonstrated Enbrel significantly improved scalp involvement in adult patients with moderate to severe plaque psoriasis, compared with placebo. The data will be presented today at the 69th Annual American Academy of Dermatology meeting in New Orleans, La.” View full resource at news-medical.net
Most Recently Shared on February 5, 2011 at 9:08 am By:
Amgen, Pfizer present Enbrel new trial results against psoriasis at 69th AAD meeting in New Orleans, La: Amgen a... http://bit.ly/f8qqic
Medical News: Antibody Efficacious in Psoriasis of the Hands and Feet - in Dermatology, Psoriasis from MedPage Today
medpagetoday.com — “A biological agent is safe and efficacious in treating severe chronic plaque psoriasis involving the hands and feet, researchers reported.” View full resource at medpagetoday.com
Most Recently Shared on December 21, 2010 at 11:00 pm By:
Antibody Efficacious in Psoriasis of the Hands and Feet (CME/CE): (MedPage Today) -- A… http://goo.gl/fb/9HmsV
Medical News: Antibody Efficacious in Psoriasis of the Hands and Feet - in Dermatology, Psoriasis from MedPage Today
medpagetoday.com — “A biological agent is safe and efficacious in treating severe chronic plaque psoriasis involving the hands and feet, researchers reported.” View full resource at medpagetoday.com
Most Recently Shared on December 21, 2010 at 10:58 pm By:
Antibody Efficacious in Psoriasis of the Hands and Feet (CME/CE) http://bit.ly/gjtKn4
Advertisement
Julie Bohlen
@J_Bohlen
Plaque psoriasis is the most common type of psoriasis, characterized by plaque formation on the skin. Learn more. http://bit.ly/dwIkMT
1 year ago...